Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phillip J Gray

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Oncology (Williston Park, N.Y.)|November 29, 2013
T1 high-grade bladder cancer recurring after BCG therapy: a curative alternative to radical cystectomy exists. ConPhillip J Gray, William U Shipley, Jason A Efstathiou
European Urology|March 15, 2016
Words of Wisdom. Re: Radical Cystectomy vs. Chemoradiation in T2-4aN0M0 Bladder Cancer: A Case-control StudyPhillip J Gray, Jason A Efstathiou, William U Shipley
Methods (San Diego, Calif.)|October 9, 2007
Cell surface receptors for molecular chaperonesStuart K Calderwood, Jimmy Theriault, Phillip J Gray, et al.
Seminars in Oncology|August 8, 2006
Tubulin-associated drug targets: Aurora kinases, Polo-like kinases, and othersSteven L Warner, Phillip J Gray, Daniel D Von Hoff
European Urology|April 22, 2015
Declining Use of Radiotherapy for Adverse Features After Radical Prostatectomy: Results From the National Cancer Data BaseHelmneh M Sineshaw, Phillip J Gray, Jason A Efstathiou, et al.
Journal of the National Cancer Institute|May 10, 2015
Androgen deprivation with or without radiation therapy for clinically node-positive prostate cancerChun Chieh Lin, Phillip J Gray, Ahmedin Jemal, et al.
Journal of the National Cancer Institute|July 26, 2015
ResponseChun Chieh Lin, Phillip J Gray, Ahmedin Jemal, et al.
Current Opinion in Urology|July 16, 2013
Recent advances and the emerging role for chemoradiation in nonmuscle invasive bladder cancerPhillip J Gray, William U Shipley, Jason A Efstathiou, et al.
Nature Reviews. Cancer|May 31, 2008
Targeting the oncogene and kinome chaperone CDC37Phillip J Gray, Thomas Prince, Jinrong Cheng, et al.
European Urology|September 7, 2016
Temporal Trends and the Impact of Race, Insurance, and Socioeconomic Status in the Management of Localized Prostate CancerPhillip J Gray, Chun Chieh Lin, Matthew R Cooperberg, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Oncology (Williston Park, N.Y.)|November 29, 2013
T1 high-grade bladder cancer recurring after BCG therapy: a curative alternative to radical cystectomy exists. ConPhillip J Gray, William U Shipley, Jason A Efstathiou
European Urology|March 15, 2016
Words of Wisdom. Re: Radical Cystectomy vs. Chemoradiation in T2-4aN0M0 Bladder Cancer: A Case-control StudyPhillip J Gray, Jason A Efstathiou, William U Shipley
Methods (San Diego, Calif.)|October 9, 2007
Cell surface receptors for molecular chaperonesStuart K Calderwood, Jimmy Theriault, Phillip J Gray, et al.
Seminars in Oncology|August 8, 2006
Tubulin-associated drug targets: Aurora kinases, Polo-like kinases, and othersSteven L Warner, Phillip J Gray, Daniel D Von Hoff
European Urology|April 22, 2015
Declining Use of Radiotherapy for Adverse Features After Radical Prostatectomy: Results From the National Cancer Data BaseHelmneh M Sineshaw, Phillip J Gray, Jason A Efstathiou, et al.
Journal of the National Cancer Institute|May 10, 2015
Androgen deprivation with or without radiation therapy for clinically node-positive prostate cancerChun Chieh Lin, Phillip J Gray, Ahmedin Jemal, et al.
Journal of the National Cancer Institute|July 26, 2015
ResponseChun Chieh Lin, Phillip J Gray, Ahmedin Jemal, et al.
Current Opinion in Urology|July 16, 2013
Recent advances and the emerging role for chemoradiation in nonmuscle invasive bladder cancerPhillip J Gray, William U Shipley, Jason A Efstathiou, et al.
Nature Reviews. Cancer|May 31, 2008
Targeting the oncogene and kinome chaperone CDC37Phillip J Gray, Thomas Prince, Jinrong Cheng, et al.
European Urology|September 7, 2016
Temporal Trends and the Impact of Race, Insurance, and Socioeconomic Status in the Management of Localized Prostate CancerPhillip J Gray, Chun Chieh Lin, Matthew R Cooperberg, et al.
Pageof 4